No Data
No Data
Mingchen HealthLtd (SZSE:002919) Jumps 12% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Mingchen Health: 2024 Semi-Annual Report Summary
Mingchen Health: 2024 Semi-Annual Report
Mingchen Health (002919.SZ): The net income in the first half of the year was 60.3629 million yuan, a year-on-year decrease of 39.42%.
Gelonghui August 29th | Mingchen Health (002919.SZ) announced the 2024 interim report, with revenue of 0.665 billion yuan during the reporting period, a year-on-year decrease of 21.30%; net income attributable to the shareholders of the listed company was 60.3629 million yuan, a year-on-year decrease of 39.42%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 58.6111 million yuan, a year-on-year decrease of 40.69%; and the basic earnings per share was 0.23 yuan.
Mingchen Health (002919.SZ) released its performance for the first half of the year, with a net income of 60.3629 million yuan, a decrease of 39.42%.
Mingchen Health (002919.SZ) released its 2024 interim report. During the reporting period, the company achieved revenue...
Mingchen Health (002919.SZ): The product "Boundary Blade Resonance" did indeed achieve a new record of reservations on the partner's official website.
Mingchen Health (002919.SZ) stated on the investor interaction platform on August 16 that the reserved volume of the company's product "Jing·Jie Dao Ming" on the partner's official website has indeed reached a new high, and the company's team and relevant parties are closely following up on the progress of the later stage work. We have always paid attention to the field that you mentioned and have certain reserves of talents and technology. The company has already had reserves in the field of small games and will continue to release products.
No Data
No Data